2012
91. Optimization of magnetic nanoparticle-assisted lentiviral gene transfer.
Trueck C, Zimmermann K, Mykhaylyk O, Anton M, Vosen S, Wenzel D, Fleischmann BK, Pfeifer A
Pharm Res. 2012 May .
92. Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria.
Mykhaylyk O, Sobisch T, Almstätter I, Sanchez-Antequera Y, Brandt S, Anton M, Döblinger M, Eberbeck D, Settles M, Braren R, Lerche D, Plank C
Pharm Res. 2012 May .
93. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
Hucke S, Floßdorf J, Grützke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brüstle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L
Brain. 2012 May .
94. Site directed vascular gene delivery in vivo by ultrasonic destruction of magnetic nanoparticle coated microbubbles.
Mannell H, Pircher J, Fochler F, Stampnik Y, Räthel T, Gleich B, Plank C, Mykhaylyk O, Dahmani C, Wörnle M, Ribeiro A, Pohl U, Krötz F
Nanomedicine. 2012 Nov .
95. Magnetic nanoparticles for biomedical applications.
Pfeifer A, Zimmermann K, Plank C
Pharm Res. 2012 May .
97. KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.
Brockschmidt A, Trost D, Peterziel H, Zimmermann K, Ehrler M, Grassmann H, Pfenning PN, Waha A, Wohlleber D, Brockschmidt FF, Jugold M, Hoischen A, Kalla C, Waha A, Seifert G, Knolle PA, Latz E, Hans VH, Wick W, Pfeifer A, Angel P, Weber RG
Brain. 2012 Apr .
99. CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells.
Poppensieker K, Otte DM, Schürmann B, Limmer A, Dresing P, Drews E, Schumak B, Klotz L, Raasch J, Mildner A, Waisman A, Scheu S, Knolle P, Förster I, Prinz M, Maier W, Zimmer A, Alferink J
Proc Natl Acad Sci U S A. 2012 Mar 6.
100. Living in the liver: hepatic infections.
Protzer U, Maini MK, Knolle PA
Nat Rev Immunol. 2012 Mar .
